129 related articles for article (PubMed ID: 1899479)
21. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of action of a dominant-negative mutant of c-Jun.
Brown PH; Chen TK; Birrer MJ
Oncogene; 1994 Mar; 9(3):791-9. PubMed ID: 8108121
[TBL] [Abstract][Full Text] [Related]
23. The designed protein M(II)-Gly-Lys-His-Fos(138-211) specifically cleaves the AP-1 binding site containing DNA.
Harford C; Narindrasorasak S; Sarkar B
Biochemistry; 1996 Apr; 35(14):4271-8. PubMed ID: 8605175
[TBL] [Abstract][Full Text] [Related]
24. Defective induction of Jun and Fos-related proteins in phorbol ester-resistant EL4 mouse thymoma cells.
Jensen DE; Frankis RC; Sando JJ
Oncogene; 1991 Jul; 6(7):1219-25. PubMed ID: 1713662
[TBL] [Abstract][Full Text] [Related]
25. In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes.
Bannister AJ; Cook A; Kouzarides T
Oncogene; 1991 Jul; 6(7):1243-50. PubMed ID: 1907361
[TBL] [Abstract][Full Text] [Related]
26. The carboxy terminus of the viral Jun oncoprotein is required for complex formation with the cellular Fos protein.
Bos TJ; Rauscher FJ; Curran T; Vogt PK
Oncogene; 1989 Feb; 4(2):123-6. PubMed ID: 2494630
[TBL] [Abstract][Full Text] [Related]
27. Integrity of FOS B leucine zipper is essential for its interaction with JUN proteins.
Ryseck RP; Kovary K; Bravo R
Oncogene; 1990 Jul; 5(7):1091-3. PubMed ID: 2115643
[TBL] [Abstract][Full Text] [Related]
28. Uncoiling c-Jun coiled coils: inhibitory effects of truncated Fos peptides on Jun dimerization and DNA binding in vitro.
Yao S; Brickner M; Pares-Matos EI; Chmielewski J
Biopolymers; 1998; 47(4):277-83. PubMed ID: 10036969
[TBL] [Abstract][Full Text] [Related]
29. Altered protein conformation on DNA binding by Fos and Jun.
Patel L; Abate C; Curran T
Nature; 1990 Oct; 347(6293):572-5. PubMed ID: 2120592
[TBL] [Abstract][Full Text] [Related]
30. Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA.
Chen L; Glover JN; Hogan PG; Rao A; Harrison SC
Nature; 1998 Mar; 392(6671):42-8. PubMed ID: 9510247
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es).
Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A
Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873
[TBL] [Abstract][Full Text] [Related]
32. Cross-talk in signal transduction: TPA-inducible factor jun/AP-1 activates cAMP-responsive enhancer elements.
Sassone-Corsi P; Ransone LJ; Verma IM
Oncogene; 1990 Mar; 5(3):427-31. PubMed ID: 2107494
[TBL] [Abstract][Full Text] [Related]
33. A ubiquitous nuclear protein stimulates the DNA-binding activity of fos and jun indirectly.
Abate C; Luk D; Curran T
Cell Growth Differ; 1990 Oct; 1(10):455-62. PubMed ID: 2126189
[TBL] [Abstract][Full Text] [Related]
34. Transactivation activity of Maf nuclear oncoprotein is modulated by Jun, Fos and small Maf proteins.
Kataoka K; Noda M; Nishizawa M
Oncogene; 1996 Jan; 12(1):53-62. PubMed ID: 8552399
[TBL] [Abstract][Full Text] [Related]
35. Both Jun and Fos contribute to transcription activation by the heterodimer.
Hirai S; Bourachot B; Yaniv M
Oncogene; 1990 Jan; 5(1):39-46. PubMed ID: 2108402
[TBL] [Abstract][Full Text] [Related]
36. Jun and v-jun contain multiple regions that participate in transcriptional activation in an interdependent manner.
Angel P; Smeal T; Meek J; Karin M
New Biol; 1989 Oct; 1(1):35-43. PubMed ID: 2518690
[TBL] [Abstract][Full Text] [Related]
37. Addition of positively charged tripeptide to N-terminus of the Fos basic region leucine zipper domain: implications on DNA bending, affinity, and specificity.
Mahmoudi T; Sarkar B
Biopolymers; 1999 Sep; 50(3):273-86. PubMed ID: 10397789
[TBL] [Abstract][Full Text] [Related]
38. DNA-binding and dimerization domains of adenosine 3',5'- cyclic monophosphate-responsive protein CREB reside in the carboxyl-terminal 66 amino acids.
Yun YD; Dumoulin M; Habener JF
Mol Endocrinol; 1990 Jun; 4(6):931-9. PubMed ID: 2146495
[TBL] [Abstract][Full Text] [Related]
39. Fos-Jun interaction: mutational analysis of the leucine zipper domain of both proteins.
Ransone LJ; Visvader J; Sassone-Corsi P; Verma IM
Genes Dev; 1989 Jun; 3(6):770-81. PubMed ID: 2501150
[TBL] [Abstract][Full Text] [Related]
40. Modification of DNA topoisomerase II activity via direct interactions with the cyclic adenosine-3',5'-monophosphate response element-binding protein and related transcription factors.
Kroll DJ; Sullivan DM; Gutierrez-Hartmann A; Hoeffler JP
Mol Endocrinol; 1993 Mar; 7(3):305-18. PubMed ID: 8387155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
